MYO-X by MHP
Myostatin Inhibitor Technology
In recent years, there's been quite a bit of speculation and research devoted to the idea that muscle growth can be enhanced by employing a mechanism that would reduce serum levels of myostatin, a genetic protein that functions as a restrictor of muscle mass increase. This scientific investigation has shown signs of promise at times, and now MHP has brought a product to market which they say has a capacity to modulate myostatin levels in athletes. Indeed, the manufacturers of MYO-X point to a clinical study conducted with healthy adult males, in which average serum myostatin reductions of 46% (in as little as 12 hours) were documented in subjects who were administered a single serving of MYO-T12, the primary active ingredient in MYO-X. This product and its active component are an interesting development in mass-building science, and worthy of more investigation and analysis.
|* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |